On Thursday, IQVIA Holdings Inc (NYSE:IQV) reported a fourth adjusted EPS of $3.12, up from $2.84, beating the consensus of $3.11.
Provider of advanced analytics reported sales of $3.96 billion, almost in line with the consensus of $3.94 billion.
Revenue increased 2.3% on a reported basis and 3.0% at constant currency.
Technology & Analytics Solutions (TAS) revenue of $1.66 billion grew 8.3% on a reported basis and 9.5% at constant currency.
Research & Development Solutions (R&DS) revenue of $2.123 billion decreased 1.3% on a reported basis and 1.0% at constant currency.
R&DS contracted backlog, including reimbursed expenses, was $31.1 billion, growing 4.4% year-over-year and 5.5% at constant currency.
The company expects approximately $7.9 billion of this backlog to convert to revenue in the next twelve months. The fourth-quarter book-to-bill ratio was 1.20x, resulting in a trailing-twelve-month book-to-bill ratio of 1.19x
“IQVIA delivered excellent fourth quarter performance, closing out a strong 2024,” said Ari Bousbib, chairman and CEO of IQVIA. “R&DS revenue was on target and bookings exceeded our expectations despite the choppy CRO market environment. TAS revenue was above target and momentum continues to build into 2025.”
Guidance: IQVIA Holdings reaffirms its 2025 outlook for sales of $15.725 billion—$16.125 billion versus a consensus of $16.03 billion.
The company sees adjusted EPS of $11.70-$12.10 versus the consensus of $11.88 and adjusted EBITDA of $3.765 billion—$3.885 billion.
William Blair analyst Max Smock writes IQVIA’s management acknowledged that the contract research organization market remains uncertain.
However, stronger-than-expected bookings in the R&DS segment boost confidence in achieving mid-single-digit revenue growth for 2025, excluding COVID-related revenue.
Meanwhile, the TAS segment showed solid momentum, with 9.5% constant-currency revenue growth—150 basis points above expectations—suggesting IQVIA's 5%-7% growth target for 2025 may be conservative.
William Blair maintains the Outperform rating.
Price Action: IQV stock is up 2.8% at $211.36 at last check Thursday.
Read Next:
Photo by Gorodenkoff on Shutterstock
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。